Discovery of super soft-drug modulators of sphingosine-1-phosphate receptor 1

The oral S1PR1 agonist ponesimod demonstrated substantial efficacy in a phase II clinical trial of psoriasis. Unfortunately, systemic side effects were observed, which included lymphopenia and transient bradycardia. We sought to develop a topical soft-drug S1PR1 agonist with an improved therapeutic...

Descripción completa

Detalles Bibliográficos
Autores principales: Bell, Mark, Foley, David, Naylor, Claire, Robinson, Colin, Riley, Jennifer, Epemolu, Ola, Scullion, Paul, Shishikura, Yoko, Katz, Elad, McLean, W.H. Irwin, Wyatt, Paul, Read, Kevin D., Woodland, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science Ltd 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6185871/
https://www.ncbi.nlm.nih.gov/pubmed/30143424
http://dx.doi.org/10.1016/j.bmcl.2018.07.044

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6185871/
https://www.ncbi.nlm.nih.gov/pubmed/30143424
http://dx.doi.org/10.1016/j.bmcl.2018.07.044

Ejemplares similares